Vulcan Value Partners Upped Cvs Health (CVS) Position; Northstar Realty Europe (NRE) Shorts Down By 20.58%

December 9, 2017 - By wolcottdaily

Vulcan Value Partners Llc increased Cvs Health Corp (CVS) stake by 1.36% reported in 2017Q2 SEC filing. Vulcan Value Partners Llc acquired 102,834 shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The Vulcan Value Partners Llc holds 7.69 million shares with $618.69 million value, up from 7.59M last quarter. Cvs Health Corp now has $74.05 billion valuation. The stock increased 2.81% or $2 during the last trading session, reaching $73.09. About 12.51 million shares traded or 40.26% up from the average. CVS Health Corporation (NYSE:CVS) has declined 24.40% since December 9, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Northstar Realty Europe Corporation (NYSE:NRE) had a decrease of 20.58% in short interest. NRE’s SI was 353,200 shares in December as released by FINRA. Its down 20.58% from 444,700 shares previously. With 163,600 avg volume, 2 days are for Northstar Realty Europe Corporation (NYSE:NRE)’s short sellers to cover NRE’s short positions. The SI to Northstar Realty Europe Corporation’s float is 0.81%. The stock increased 0.28% or $0.04 during the last trading session, reaching $14.23. About 158,051 shares traded. Northstar Realty Europe Corp. (NYSE:NRE) has risen 4.98% since December 9, 2016 and is uptrending. It has underperformed by 11.72% the S&P500.

Among 25 analysts covering CVS Health (NYSE:CVS), 17 have Buy rating, 0 Sell and 8 Hold. Therefore 68% are positive. CVS Health had 58 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of CVS Health Corporation (NYSE:CVS) earned “Neutral” rating by Atlantic Securities on Monday, February 6. Jefferies maintained CVS Health Corporation (NYSE:CVS) on Thursday, May 12 with “Buy” rating. The stock has “Overweight” rating by JP Morgan on Monday, November 2. The firm has “Outperform” rating by Oppenheimer given on Monday, November 2. The firm has “Hold” rating given on Monday, September 25 by Robert W. Baird. The stock of CVS Health Corporation (NYSE:CVS) has “Outperform” rating given on Friday, January 22 by Robert W. Baird. The firm has “Neutral” rating given on Monday, November 13 by Citigroup. Morgan Stanley downgraded CVS Health Corporation (NYSE:CVS) rating on Monday, June 20. Morgan Stanley has “Equal-Weight” rating and $104 target. The rating was downgraded by Goldman Sachs to “Neutral” on Thursday, December 17. Needham maintained the shares of CVS in report on Monday, December 4 with “Buy” rating.

Vulcan Value Partners Llc decreased Qorvo Inc stake by 1.66 million shares to 3.93M valued at $248.58M in 2017Q2. It also reduced Moodys Corp (NYSE:MCO) stake by 22,005 shares and now owns 1.63M shares. Aci Worldwide Inc (NASDAQ:ACIW) was reduced too.

Investors sentiment decreased to 0.92 in 2017 Q2. Its down 0.17, from 1.09 in 2017Q1. It dived, as 84 investors sold CVS shares while 559 reduced holdings. 108 funds opened positions while 483 raised stakes. 803.96 million shares or 0.96% less from 811.73 million shares in 2017Q1 were reported. Puzo Michael J holds 68,285 shares. Hexavest reported 1.12% in CVS Health Corporation (NYSE:CVS). Bluemountain Ltd Liability Corporation reported 21,652 shares stake. Vanguard Group Incorporated owns 76.56M shares. Fernwood Mngmt Ltd Llc reported 48,773 shares stake. Riverhead Capital Mgmt Ltd Co invested 0.39% of its portfolio in CVS Health Corporation (NYSE:CVS). 3,118 are owned by Mckinley Carter Wealth Service. Wellington Shields Com Ltd Liability Com invested in 0.18% or 6,500 shares. Cambiar Ltd Limited Liability Company owns 832,971 shares. Mark Sheptoff Fin Planning Ltd Liability stated it has 2.88% of its portfolio in CVS Health Corporation (NYSE:CVS). Stratos Wealth Prns owns 0.36% invested in CVS Health Corporation (NYSE:CVS) for 85,891 shares. 35,581 were accumulated by Rand Wealth Ltd Liability. Peloton Wealth Strategists owns 26,225 shares for 1.64% of their portfolio. Montag A Associates owns 45,842 shares for 0.41% of their portfolio. Virginia-based Markel has invested 0.46% in CVS Health Corporation (NYSE:CVS).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By :